About Gilead
Gilead is a company based in Foster City (United States) founded in 1987 was acquired by Citadel in October 2016.. The company has 17,600 employees as of December 31, 2024. Gilead has completed 18 acquisitions, including Arresto BioSciences, CGI Pharmaceuticals and CV Therapeutics. Gilead offers products and services including Antiviral Medicines, Oncology Drugs, and Inflammation Treatments. Gilead operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Foster City, United States
- Employees 17600 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gilead Sciences, Inc.
-
Annual Revenue
$28.73 B6.17as on Dec 31, 2024
-
Net Profit
$480 M-91.53as on Dec 31, 2024
-
EBITDA
$13.43 B7.96as on Dec 31, 2024
-
Latest Funding Round
$290 K (USD), Post-IPO
Jan 27, 2025
-
Investors
Wealth Enhancement
& 8 more
-
Employee Count
17600
as on Dec 31, 2024
-
Investments & Acquisitions
Arresto BioSciences
& 17 more
-
Acquired by
Citadel
(Oct 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gilead
Gilead is a publicly listed company on the NASDAQ with ticker symbol GILD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Gilead
Gilead offers a comprehensive portfolio of products and services, including Antiviral Medicines, Oncology Drugs, and Inflammation Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for HIV, viral hepatitis, and emerging viruses
Therapies for cancer and related conditions
Medicines for inflammatory diseases and disorders
Unlock access to complete
Unlock access to complete
Leadership Team
294 people
Software Development Team
183 people
Senior Team
62 people
Legal and Compliance
41 people
Data Analysis and Operations Team
38 people
Human Resources and Administration
38 people
Operations Team
38 people
Finance and Accounting
36 people
Unlock access to complete
Funding Insights of Gilead
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $290,000
-
First Round
First Round
(01 Jul 2010)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Post-IPO - Gilead | Valuation |
investors |
|
| Jul, 2020 | Amount | Grant - Gilead | Valuation |
investors |
|
| Jan, 2020 | Amount | Grant - Gilead | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gilead
Gilead has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Wealth Enhancement, DriveWealth and Citadel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors including healthcare are invested in by IFM Investors.
|
Founded Year | Domain | Location | |
|
Cloud-based API solutions for embedded investing are provided online.
|
Founded Year | Domain | Location | |
|
Investment management services are offered by Bellevue in Switzerland.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gilead
Gilead has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include Arresto BioSciences, CGI Pharmaceuticals and CV Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small-molecule therapeutics for immuno-oncology diseases are developed.
|
2021 | ||||
|
Developer of therapeutics for auto-immune diseases
|
2019 | ||||
|
CAR T-cell immunotherapies for cancer and diseases are developed.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Gilead
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gilead Comparisons
Competitors of Gilead
Gilead operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gilead
Frequently Asked Questions about Gilead
When was Gilead founded?
Gilead was founded in 1987 and raised its 1st funding round 23 years after it was founded.
Where is Gilead located?
Gilead is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
How many employees does Gilead have?
As of Dec 31, 2024, the latest employee count at Gilead is 17,600.
What is the annual revenue of Gilead?
Annual revenue of Gilead is $28.73B as on Dec 31, 2024.
What does Gilead do?
Founded in 1987 and headquartered in Foster City, United States, Gilead operates as a research-based biopharmaceutical company. Innovative medicines are discovered, developed, and commercialized to address unmet medical needs in HIVAIDS, liver diseases, and cancer. Key developments include the Lenacapavir capsid inhibitor for HIV and the Selgantolimod TLR-8 agonist for HBV. In 2022, annual revenues of 27.28 billion and net profit of 4.59 billion were recorded.
Who are the top competitors of Gilead?
Gilead's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Gilead offer?
Gilead offers Antiviral Medicines, Oncology Drugs, and Inflammation Treatments.
Is Gilead publicly traded?
Yes, Gilead is publicly traded on NASDAQ under the ticker symbol GILD.
How many acquisitions has Gilead made?
Gilead has made 18 acquisitions, including Arresto BioSciences, CGI Pharmaceuticals, and CV Therapeutics.
Who are Gilead's investors?
Gilead has 9 investors. Key investors include Wealth Enhancement, DriveWealth, Citadel, Bellevue, and European Union.
What is Gilead's ticker symbol?
The ticker symbol of Gilead is GILD on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.